Cochlear Limited (FRA:OC5)
Germany · Delayed Price · Currency is EUR 156.42
-0.76 (-0.48%)
At close: Nov 28, 2025
Cochlear Company Description
Cochlear Limited provides implantable hearing solutions for children and adults worldwide.
The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products.
It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories.
The company was founded in 1981 and is headquartered in Sydney, Australia.
Cochlear Limited
| Country | Australia |
| Founded | 1981 |
| Industry | Orthopedic, Prosthetic, and Surgical Appliances and Supplies |
| Employees | 5,500 |
| CEO | Diggory Howitt |
Contact Details
Address: 1 University Avenue Sydney, 2109 Australia | |
| Phone | 61 2 9428 6555 |
| Website | cochlear.com |
Stock Details
| Ticker Symbol | OC5 |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Diggory Howitt | Chief Executive Officer |
| Sarah Thom | Chief Financial Officer |
| Kristina Devon | Head of Investor Relations |